ArticleTranslational cancer research2021

MiR-137 inhibits cervical cancer progression via down-modulating Notch1 and inhibiting the PI3K/AKT/mTOR signaling pathway.

Ying Gui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.